• Explore /
  • Poster
  • / Phase 2 study of olaparib (without ADT) in men with biochemically recurrent prostate cancer (BCR) after prostatectomy.

Phase 2 study of olaparib (without ADT) in men with biochemically recurrent prostate cancer (BCR) after prostatectomy.

Abstract Poster

Authors

Catherine Marshall

Catherine Handy Marshall

Johns Hopkins University, Baltimore, MD

Catherine Handy Marshall , Benjamin A. Teply , Su Jin Lim , Hao Wang , Shifeng S. Mao , William Kevin Kelly , Channing Judith Paller , Mark Christopher Markowski , Samuel R. Denmeade , Michael Anthony Carducci , Mario A. Eisenberger , Serina King , Rana Sullivan , Tamara L. Lotan , Emmanuel S. Antonarakis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Hormone-Sensitive

Clinical Trial Registration Number

NCT03047135

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5087)

DOI

10.1200/JCO.2023.41.16_suppl.5087

Abstract #

5087

Poster Bd #

181

Abstract Disclosures

Similar Posters

First Author: Anup Kasi

First Author: Kamal Kant Kant Sahu

First Author: Severine Guiu Lahaye

First Author: Yasser Ged